Cargando…

MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation

Clinical data indicate that patients with C-reactive protein (CRP) levels higher than 2 mg per liter suffer from persistent inflammation, which is associated with high risk of cardiovascular disease (CVD). We determined whether a panel of biomarkers associated with CVD could predict recurrent events...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco-Colio, Luis M., Méndez-Barbero, Nerea, Pello Lázaro, Ana María, Aceña, Álvaro, Tarín, Nieves, Cristóbal, Carmen, Martínez-Milla, Juan, González-Lorenzo, Óscar, Martín-Ventura, José Luis, Huelmos, Ana, Gutiérrez-Landaluce, Carlos, López-Castillo, Marta, Kallmeyer, Andrea, Cánovas, Ester, Alonso, Joaquín, López Bescós, Lorenzo, Egido, Jesús, Lorenzo, Óscar, Tuñón, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963189/
https://www.ncbi.nlm.nih.gov/pubmed/33803115
http://dx.doi.org/10.3390/jcm10051137
_version_ 1783665585054285824
author Blanco-Colio, Luis M.
Méndez-Barbero, Nerea
Pello Lázaro, Ana María
Aceña, Álvaro
Tarín, Nieves
Cristóbal, Carmen
Martínez-Milla, Juan
González-Lorenzo, Óscar
Martín-Ventura, José Luis
Huelmos, Ana
Gutiérrez-Landaluce, Carlos
López-Castillo, Marta
Kallmeyer, Andrea
Cánovas, Ester
Alonso, Joaquín
López Bescós, Lorenzo
Egido, Jesús
Lorenzo, Óscar
Tuñón, José
author_facet Blanco-Colio, Luis M.
Méndez-Barbero, Nerea
Pello Lázaro, Ana María
Aceña, Álvaro
Tarín, Nieves
Cristóbal, Carmen
Martínez-Milla, Juan
González-Lorenzo, Óscar
Martín-Ventura, José Luis
Huelmos, Ana
Gutiérrez-Landaluce, Carlos
López-Castillo, Marta
Kallmeyer, Andrea
Cánovas, Ester
Alonso, Joaquín
López Bescós, Lorenzo
Egido, Jesús
Lorenzo, Óscar
Tuñón, José
author_sort Blanco-Colio, Luis M.
collection PubMed
description Clinical data indicate that patients with C-reactive protein (CRP) levels higher than 2 mg per liter suffer from persistent inflammation, which is associated with high risk of cardiovascular disease (CVD). We determined whether a panel of biomarkers associated with CVD could predict recurrent events in patients with low or persistent inflammation and coronary artery disease (CAD). We followed 917 patients with CAD (median 4.59 ± 2.39 years), assessing CRP, galectin-3, monocyte chemoattractant protein-1 (MCP-1), N-terminal fragment of brain natriuretic peptide (NT-proBNP) and troponin-I plasma levels. The primary outcome was the combination of cardiovascular events (acute coronary syndrome, stroke or transient ischemic event, heart failure or death). Patients with persistent inflammation (n = 343) showed higher NT-proBNP and MCP-1 plasma levels compared to patients with CRP < 2 mg/L. Neither MCP-1 nor NT-proBNP was associated with primary outcome in patients with CRP < 2 mg/L. However, NT-proBNP and MCP-1 plasma levels were associated with increased risk of the primary outcome in patients with persistent inflammation. When patients were divided by type of event, MCP-1 was associated with an increased risk of acute ischemic events. A significant interaction between MCP-1 and persistent inflammation was found (synergy index: 6.17 (4.39–7.95)). In conclusion, MCP-1 plasma concentration is associated with recurrent cardiovascular events in patients with persistent inflammation.
format Online
Article
Text
id pubmed-7963189
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79631892021-03-17 MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation Blanco-Colio, Luis M. Méndez-Barbero, Nerea Pello Lázaro, Ana María Aceña, Álvaro Tarín, Nieves Cristóbal, Carmen Martínez-Milla, Juan González-Lorenzo, Óscar Martín-Ventura, José Luis Huelmos, Ana Gutiérrez-Landaluce, Carlos López-Castillo, Marta Kallmeyer, Andrea Cánovas, Ester Alonso, Joaquín López Bescós, Lorenzo Egido, Jesús Lorenzo, Óscar Tuñón, José J Clin Med Article Clinical data indicate that patients with C-reactive protein (CRP) levels higher than 2 mg per liter suffer from persistent inflammation, which is associated with high risk of cardiovascular disease (CVD). We determined whether a panel of biomarkers associated with CVD could predict recurrent events in patients with low or persistent inflammation and coronary artery disease (CAD). We followed 917 patients with CAD (median 4.59 ± 2.39 years), assessing CRP, galectin-3, monocyte chemoattractant protein-1 (MCP-1), N-terminal fragment of brain natriuretic peptide (NT-proBNP) and troponin-I plasma levels. The primary outcome was the combination of cardiovascular events (acute coronary syndrome, stroke or transient ischemic event, heart failure or death). Patients with persistent inflammation (n = 343) showed higher NT-proBNP and MCP-1 plasma levels compared to patients with CRP < 2 mg/L. Neither MCP-1 nor NT-proBNP was associated with primary outcome in patients with CRP < 2 mg/L. However, NT-proBNP and MCP-1 plasma levels were associated with increased risk of the primary outcome in patients with persistent inflammation. When patients were divided by type of event, MCP-1 was associated with an increased risk of acute ischemic events. A significant interaction between MCP-1 and persistent inflammation was found (synergy index: 6.17 (4.39–7.95)). In conclusion, MCP-1 plasma concentration is associated with recurrent cardiovascular events in patients with persistent inflammation. MDPI 2021-03-09 /pmc/articles/PMC7963189/ /pubmed/33803115 http://dx.doi.org/10.3390/jcm10051137 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Blanco-Colio, Luis M.
Méndez-Barbero, Nerea
Pello Lázaro, Ana María
Aceña, Álvaro
Tarín, Nieves
Cristóbal, Carmen
Martínez-Milla, Juan
González-Lorenzo, Óscar
Martín-Ventura, José Luis
Huelmos, Ana
Gutiérrez-Landaluce, Carlos
López-Castillo, Marta
Kallmeyer, Andrea
Cánovas, Ester
Alonso, Joaquín
López Bescós, Lorenzo
Egido, Jesús
Lorenzo, Óscar
Tuñón, José
MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
title MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
title_full MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
title_fullStr MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
title_full_unstemmed MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
title_short MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
title_sort mcp-1 predicts recurrent cardiovascular events in patients with persistent inflammation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963189/
https://www.ncbi.nlm.nih.gov/pubmed/33803115
http://dx.doi.org/10.3390/jcm10051137
work_keys_str_mv AT blancocolioluism mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT mendezbarberonerea mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT pellolazaroanamaria mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT acenaalvaro mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT tarinnieves mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT cristobalcarmen mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT martinezmillajuan mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT gonzalezlorenzooscar mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT martinventurajoseluis mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT huelmosana mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT gutierrezlandalucecarlos mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT lopezcastillomarta mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT kallmeyerandrea mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT canovasester mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT alonsojoaquin mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT lopezbescoslorenzo mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT egidojesus mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT lorenzooscar mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation
AT tunonjose mcp1predictsrecurrentcardiovasculareventsinpatientswithpersistentinflammation